Abstract
Background: Cardiovascular diseases (CVDs) are the leading cause of non-communicable disease mortality worldwide, and Bangladesh is undergoing a rapid epidemiological transition. Hypertension, the dominant modifiable CVD risk factor, has shown a pronounced upward trajectory over the past three decades. This review compares the methodology, scale, and cardiovascular outcomes of the available Bangladeshi literature to characterize the burden and its determinants.
Methods: Evidence was drawn from nationally representative surveys, systematic reviews and meta-analyses, regional cross-sectional studies, and hospital-based series. Studies were compared by design, setting, sample size, population, and reported outcomes, with particular attention to how differing diagnostic thresholds and study settings shape prevalence estimates.
Results: Pooled hypertension prevalence rose from roughly 11–14% in the late 1990s–early 2000s to an age-standardized 26.2% in the 2017– 18 national survey, and to 48.0–50.5% when the 2017 ACC/AHA threshold (≥130/80 mmHg) is applied in place of JNC 7 (≥140/90 mmHg). Among adults ≥35 years, prevalence increased from 25.8% (2011) to 39.4% (2018). Women now surpass men in hypertension prevalence from their early thirties, undiagnosed hypertension reaches 59.9% of cases, and effective blood-pressure control remains as low as 11–12.7% nationally. Coronary artery disease ranged from 4.5% in rural samples to 17.2% among diabetic hospital patients, and rural areas showed the steepest recent surges in prevalence.
Conclusions: Despite methodological heterogeneity, the literature converges on a consistent message: urbanization, ageing, and lifestyle change are driving a rising CVD burden across both urban and rural Bangladesh, and stricter diagnostic guidelines imply that close to half of adults may be hypertensive. Strengthening diagnosis, treatment adherence, and control alongside attention to regionally distinctive exposures is an urgent public-health priority. Alongside these measures, integrating sensitive circulatory and non-invasive biomarkers into primary screening protocols may further improve early risk stratification and help prevent long-term cardiovascular complications.
Keywords
Cardiovascular disease, Hypertension, Prevalence, Bangladesh, Epidemiological transition, Non-communicable disease, ACC/AHA guideline
Introduction
Cardiovascular diseases (CVDs) are the leading contributor to non-communicable disease (NCD) mortality globally, and Bangladesh is experiencing a rapid epidemiological transition in which the burden of chronic vascular conditions is expanding quickly. Demographic ageing, urbanization, and economically driven lifestyle change have combined to raise the prevalence of CVD risk factors, most conspicuously hypertension (HTN), across the population.
Characterizing this landscape is essential for aligning national public-health policy and clinical practice with the true scale of the problem. Yet prevalence estimates in the literature vary widely, reflecting differences in study design, sampling, setting, and the diagnostic thresholds applied. This review evaluates the Bangladeshi evidence on CVD and hypertension prevalence, drawing together local cross-sectional surveys, large national biomarker assessments, systematic reviews, and hospital-based series. By comparing methodologies alongside outcomes, it aims to distinguish genuine epidemiological trends from artefacts of measurement, and to identify where the evidence base remains thin.
Methods
This is a narrative comparative review of published studies reporting the prevalence of cardiovascular disease and its principal risk factors in Bangladeshi adults. Sources were grouped by study design in order to make their strengths, limitations, and comparability explicit. Four categories were distinguished:
Nationally representative surveys: Large-scale studies such as the Bangladesh Demographic and Health Survey (BDHS) provide the most robust evidence for national trends [4,10,16], typically using multistage, geographically clustered sampling of thousands of households [18].
Systematic reviews and meta-analyses: These aggregate primary studies to derive pooled prevalence estimates [1,3,5], for example, Saquib et al. synthesized 29 studies to track secular trends across 15 years [1].
Regional and localized cross-sectional studies: Targeted work in specific urban areas such as Dhaka [8,11] or rural villages such as Keraniganj [27] offers granular, community-level insight into risk factors.
Clinical and hospital-based studies: Research at tertiary facilities such as the National Institute of Cardiovascular Diseases (NICVD) and BIRDEM General Hospital focuses on patient populations and typically yields higher prevalence than general-population samples [7,14,25].
For each study, the design, setting, sample size, target population, and reported cardiovascular outcomes were extracted and tabulated (Tables 1 and 2). Particular attention was paid to the diagnostic definition used, most importantly the contrast between the older JNC 7 threshold (≥140/90 mmHg) and the 2017 ACC/AHA threshold (≥130/80 mmHg), because this single methodological choice substantially alters reported prevalence.
|
Study |
Study design |
Setting |
Sample size |
Population context |
|
[1] |
Systematic review / meta-analysis |
National |
29 studies (pooled) |
General population |
|
[2] |
Cross-sectional |
Rural villages |
Not reported |
Adults ≥18 years |
|
[4] |
Secondary analysis (BDHS) |
National |
11,686 |
Adults |
|
[5] |
Systematic review / meta-analysis |
National |
129,740 |
Bangladeshi adults |
|
[6] |
Descriptive cross-sectional |
Urban (Dhaka) |
403 prescriptions |
Cardiology patients |
|
[7] |
Descriptive study |
Urban (Dhaka) |
853 |
Hospital-based (NICVD / NHF) |
|
[8] |
Cross-sectional survey |
Urban (Dhaka) |
730 |
Residents ≥25 years |
|
[9] |
Secondary analysis (BDHS) |
National |
12,476 |
Adults ≥18 years |
|
[10] |
National survey (BDHS) |
National |
12,904 |
Adults 18–95 years |
|
[11] |
Cross-sectional |
Urban (Dhaka) |
200 |
Residents 18–65 years |
|
[13] |
National survey (BDHS) |
National |
8,835 |
Adults 35+ years |
|
[14] |
Cross-sectional |
Urban (NICVD, Dhaka) |
200 |
Indoor / outdoor patients |
|
[16] |
National survey (2 BDHS waves) |
National |
23,539 |
Adults 18+ years |
|
[18] |
National NCD survey |
National |
Representative |
Adults ≥25 years |
|
[19] |
National survey (BDHS) |
National |
7,839 |
Adults ≥35 years |
|
[23] |
Observational study |
Urban (BIRDEM) |
599 |
Officials >50 years |
|
[25] |
Cross-sectional |
Urban (BIRDEM) |
221 |
T2DM patients 30–70 years |
|
[26] |
Population-based survey |
Urban |
27,792 |
Residents vs. migrants |
|
[27] |
Cross-sectional descriptive |
Rural (Keraniganj) |
199 |
Adults ≥20 years |
|
Study |
Key cardiovascular outcome(s) |
Reported prevalence / statistic |
Not reported |
|
[1] |
Pooled hypertension |
13.7% (pooled) |
Morbidity / mortality specifics |
|
[2] |
Coronary artery disease |
4.5% overall; 6.0% male |
Sample size; mortality |
|
[4] |
HTN trends (2011–2018) |
13-point increase |
Specific clinical values |
|
[5] |
Weighted pooled CVD |
5.0% overall; 8% urban |
Subgroup CIs |
|
[7] |
Lipid disorder; HTN; heart failure |
>48%; 30%; 28.5% |
Uncertainty intervals |
|
[8] |
Age-adjusted HTN |
23.7% overall |
Mortality rates |
|
[9] |
HTN sex–age interaction |
Women higher from early 30s |
Measurement details |
|
[10] |
Age-standardized HTN |
26.2% overall |
Divisional detail |
|
[11] |
High BP; CVD |
BP 27.1% (M) / 18.4% (F); CVD 11.2% (M) |
Analysis approach |
|
[13] |
Undiagnosed HTN |
59.9% of hypertensives |
Mortality / morbidity |
|
[14] |
HTN prevalence |
43% overall; 60.3% (>50 yrs) |
Mortality outcomes |
|
[16] |
HTN increase (≥35 yrs) |
25.8% (2011) → 39.4% (2018) |
Regional prevalence |
|
[18] |
HTN and pre-hypertension |
HTN 20%; pre-HTN 43% |
Analysis approach |
|
[19] |
HTN prevalence (≥35 yrs) |
26.4% overall; 32.4% (F) |
Morbidity specifics |
|
[21] |
HTN (ACC/AHA guideline) |
50.5% overall |
Morbidity outcomes |
|
[22] |
HTN guideline comparison |
40.7% (ACC/AHA) vs. 17.9% (JNC 7) |
Sampling approach |
|
[23] |
Effective BP control |
11% national; 68.8% study group |
Analysis approach |
|
[25] |
CAD in diabetic patients |
17.2% |
Mortality rates |
|
[27] |
HTN in rural setting |
15.6% |
Measurement method |
Results
Hypertension prevalence and secular trends
Hypertension is the most extensively studied cardiovascular risk factor in Bangladesh. Pooled estimates for 1995–2010 indicated a prevalence of about 13.7% [1], but more recent national data show a marked rise: the 2017–18 BDHS reported an age-standardized prevalence of 26.2% among adults aged 18–95 years [10]. When the 2017 ACC/AHA guideline (≥130/80 mmHg) is applied instead of JNC 7 (≥140/90 mmHg), reported prevalence roughly doubles, with some studies indicating rates of 48.0–50.5% among adults [21,24].
The secular trend is unmistakable. Among adults aged ≥35 years, prevalence increased from 25.8% in 2011 to 39.4% in 2018 [16]. Gender patterns have also shifted: whereas earlier studies frequently reported higher rates in men, recent evidence indicates that women in Bangladesh surpass men in hypertension prevalence as early as their thirties [9]. This early onset warrants closer scrutiny of chronic psychosocial stress, as sustained hypothalamic–pituitary–adrenal (HPA) axis activation and altered cortisol secretion may heighten sympathetic drive and promote premature vascular stiffening in young adults; among university students, salivary cortisol has been linked to emotional intelligence and stress-management skills [33]. Alongside rising prevalence, the care cascade remains weak: undiagnosed hypertension accounts for 59.9% of hypertensive individuals [13], and effective blood-pressure control is achieved in only about 11–12.7% of cases nationally [10,23].
Coronary artery disease and stroke
Coronary artery disease (CAD) prevalence differs sharply between general and clinical populations. Rural studies have reported CAD at 4.5% [2], whereas hospital-based studies of diabetic patients report rates as high as 17.2% [25]. Other hospital-based descriptive series report lipid disorders (>48%), heart failure (28.5%), and myocardial infarction (20.9%) [7]. Because these figures capture clinically manifest disease, they are likely to miss subclinical myocardial strain and early ischemic burden, which could be detected with sensitive circulatory biomarkers such as cardiac troponin I (cTnI); salivary cTnI has been shown to correlate positively with cortisol in children, suggesting an interaction with neuro-endocrine stress responses [34]. Stroke remains a major concern: general systematic reviews estimate a weighted pooled prevalence near 1% [5], while hospital cohorts report stroke in up to 17.1% of cardiovascular patients [7], a gap that reflects the selection inherent in tertiary-care samples rather than a true population figure.
Urban–rural disparities
Geographic disparities are pronounced but narrowing. Urban areas traditionally show higher CVD prevalence (around 8%) than rural areas (around 2%) [5]. However, the rate of increase in rural settings is accelerating: one study found rural hypertension prevalence rising from 36% in 2011 to 64% in 2017–18, a faster climb than in urban centers [12]. While urbanization drives risk through sedentary lifestyles and dietary change, the rural surge indicates that cardiovascular risk factors are now penetrating every geographic sector of the country [5,19].
Comparative synthesis of the literature
Tables 1 and 2 summarize the methodological features and cardiovascular outcomes of selected key studies. Table 1 juxtaposes design, setting, sample size, and population context; Table 2 aligns the principal outcomes, the reported statistic, and the information each study did not report. Read together, they show how national surveys with large probability samples anchor the population estimates, while hospital-based and localized studies contribute higher, setting-specific figures, and finer detail on risk correlates.
Risk Factors and Demographic Determinants
Across study designs, a consistent set of determinants emerges:
Age and sex: Advancing age is universally associated with higher risk [10,14,16]. Female sex is linked to higher hypertension prevalence in recent surveys [9,15], while CAD is more often reported in men [2].
Obesity and BMI: A body-mass index ≥25 kg/m2 is a critical predictor; the largest relative increase in hypertension (97%) has been observed among obese individuals [16,24].
Lifestyle behaviors: Smoking (cigarette and biri), physical inactivity, and unhealthy diets high in salt and fat are major contributors [8,27,29]; low physical activity is especially common among urban residents [1].
Socioeconomic status: Higher wealth and education paradoxically correlate with higher hypertension prevalence in many studies [12,19,26], although low educational attainment is associated with poorer control [10].
Environmental exposures: Arsenic in drinking water and increasing salinity in coastal regions are noted as regionally distinctive cardiovascular risks [20,28,31]. Longitudinal evidence from the Health Effects of Arsenic Longitudinal Study (HEALS) cohort in Araihazar reinforces this link, showing that reductions in urinary arsenic are associated with substantially lower mortality from chronic diseases, including cardiovascular disease [32].
Discussion
The literature reveals a striking convergence of findings despite considerable methodological diversity. Estimates from probability-based national surveys, pooled meta-analyses, community studies, and hospital series differ in absolute magnitude, yet all point in the same direction: cardiovascular risk, and hypertension in particular, is rising rapidly and broadly across Bangladesh. The apparent doubling of hypertension prevalence when the ACC/AHA threshold replaces JNC 7 [21,22,24] is a useful reminder that a substantial share of the variation between studies is definitional rather than biological—two studies of the same population can report 17.9% or 40.7% depending solely on the cut-off adopted [22]. Any comparison of prevalence figures must therefore begin with the diagnostic criterion, not the headline percentage.
A second theme is the shifting demographic distribution of risk. The finding that women overtake men in hypertension prevalence from their early thirties [9] departs from global patterns and has direct implications for screening, which has often been oriented toward older men. Coupled with the very high proportion of undiagnosed disease [13] and the low rates of effective control [10,23], this suggests that the greatest gains are available not from new detection technology but from strengthening the existing care cascade: case-finding, treatment initiation, and adherence.
Third, the erosion of the urban–rural gap is consequential for health-system planning. The rapid rural surge in hypertension [12] indicates that cardiovascular prevention can no longer be treated as a predominantly metropolitan concern; primary-care and community-level interventions will need national reach. Finally, the regionally distinctive exposures, arsenic contamination and coastal salinity [28,31], mean that a uniform national strategy may under-serve climate-vulnerable and environmentally exposed communities, for whom context-specific measures are warranted; encouragingly, arsenic exposure is modifiable, and its mitigation has recently been linked to reduced chronic-disease mortality, including cardiovascular death, in a long-term Bangladeshi cohort [32].
Taken together, the evidence supports a dual response: population-level measures targeting diet, salt intake, tobacco, and physical inactivity, and health-system measures to close the diagnosis-to-control gap. Moreover, identifying early non-invasive markers of vascular and autonomic regulation, such as salivary apelin and cortisol [33,35], could enhance community-level risk stratification prior to the onset of fixed arterial hypertension, although their predictive value for cardiovascular outcomes in Bangladeshi populations has yet to be established. The consistency of the underlying signal across heterogeneous methods lends confidence that this trajectory is real rather than an artefact of any single study design.
Limitations of the Evidence Base
Self-report versus clinical measurement: Studies relying on self-reported diagnosis substantially underestimate prevalence relative to objective measurement [17,22].
Regional imbalance: Much focused research clusters around Dhaka and a few divisions, potentially missing variation in regions such as Barisal or Sylhet [1,6].
Scarcity of longitudinal data: Most studies are cross-sectional, limiting inference about causal relationships between risk factors and disease onset [20].
Missing outcomes in primary reporting: Reviews repeatedly note under-reporting of mortality, specific morbidity outcomes, and uncertainty intervals in primary studies [1,20], as reflected in the “not reported” column of Table 2.
Research Gaps and Future Directions
Nationwide clinical surveys: There is an urgent need for large-scale, nationwide surveys that combine clinical measurement with socioeconomic analysis to characterize hypertension comprehensively [20].
Mechanistic studies: The contributions of ACE gene polymorphism, hypovitaminosis D, and mass arsenic exposure to cardiovascular health remain inadequately studied [20]; recent cohort evidence linking arsenic mitigation to reduced cardiovascular mortality [32] represents progress but warrants replication with cardiovascular-specific endpoints and prevalence measures.
Treatment and control: With control rates as low as 11–12.7% [10,23], research on strengthening the hypertension care cascade and improving adherence, including to generic medicines, is needed [6,18].
Biomarker-based risk stratification: Studies are needed to test whether sensitive circulatory and non-invasive biomarkers, such as cTnI and salivary apelin and cortisol, add predictive value to blood-pressure-based screening in Bangladeshi primary-care and community settings [33–35].
Conclusion
The prevalence of cardiovascular disease and hypertension in Bangladesh has reached alarming levels and continues to rise. Across methodologically varied studies, the core findings are consistent: urbanization and lifestyle change are driving a surge in cardiovascular risk factors in both urban and rural populations. Under contemporary diagnostic guidelines, nearly half of the adult population may be hypertensive, imposing a heavy and growing burden on the health system. Future efforts should prioritize improving diagnostic awareness, enhancing treatment adherence and control, and addressing the diverse lifestyle and environmental risk factors specific to the Bangladeshi context. Alongside these priorities, integrating sensitive circulatory and non-invasive biomarkers into primary screening protocols could support earlier risk stratification and help prevent long-term cardiovascular complications.
Declarations
Funding
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Conflicts of interest
The authors declare that they have no competing interests.
Ethical approval
Not applicable. This article is a review of previously published literature and did not involve new data collection from human participants or animals.
Consent to participate / for publication
Not applicable.
Data availability
Not applicable. All data discussed in this review are available in the cited, published sources.
Author contributions
Conceptualization and drafting of the manuscript: Sufi Sumsul Yeaman; Literature search and screening: Md. Mohasin Uddin; Data extraction and synthesis: Mohammad Ali Asraf Suhag; Critical revision for important intellectual content: Saidunnessa. All authors read and approved the final manuscript.
References
2. Banerjeel SK, Ahmed CM, Rhaman MM, Chowdhury MM, Sayeed MA. Coronary artery disease in a rural population of Bangladesh: is dyslipidemia or adiposity a significant risk?. IMC Journal of Medical Science. 2017 Jul 4;11(2):61–9.
3. Hoq MI, Hossain M, Jahan S, Mahmud H, Akter F, Mahmud F, et al. Trends in the Prevalence of Hypertension and Type 2 Diabetes in Bangladesh (2010-2020): A Systematic Review and Meta-Analysis. Curr Diabetes Rev. 2023;19(6):e290422204250.
4. Sathi NJ, Islam MA, Ahmed MS, Islam SMS. Prevalence, trends and associated factors of hypertension and diabetes mellitus in Bangladesh: Evidence from BHDS 2011 and 2017-18. PLoS One. 2022 May 3;17(5):e0267243.
5. Chowdhury MZI, Haque MA, Farhana Z, Anik AM, Chowdhury AH, Haque SM, et al. Prevalence of cardiovascular disease among Bangladeshi adult population: a systematic review and meta-analysis of the studies. Vasc Health Risk Manag. 2018 Aug 21;14:165–81.
6. Sultana J, Jahan A, Saifuddin M, Reza MS. Factors affecting the prescription pattern of generic cardiovascular medicines: A cross-sectional study in Dhaka City. Dhaka University Journal of Pharmaceutical Sciences. 2022 Jun 9:337–46.
7. Rahman A, Raka SC, Ahmed SM. Prevalence of cardiovascular diseases and prescription patterns in a randomly selected population in Bangladesh. Biomed Pharmacol J. 2017;10(2):607–13.
8. Islam SM, Mainuddin A, Islam MS, Karim MA, Mou SZ, Arefin S, et al. Prevalence of risk factors for hypertension: A cross-sectional study in an urban area of Bangladesh. Glob Cardiol Sci Pract. 2015 Nov 20;2015(4):43.
9. Iqbal A, Rahman MM, Bashar M, Ahmed A, Khan S, Ahmed N, et al. Hypertension in Bangladesh: women surpass men at younger ages than worldwide. J Glob Health. 2025 Jun 20;15:04138.
10. Khan MN, Oldroyd JC, Chowdhury EK, Hossain MB, Rana J, Renzetti S, et al. Prevalence, awareness, treatment, and control of hypertension in Bangladesh: Findings from National Demographic and Health Survey, 2017-2018. J Clin Hypertens (Greenwich). 2021 Oct;23(10):1830–42.
11. Mondal LR, Reza T, Ashrafi A. Demographic and Nutritional Influences on Cardiometabolic Health and Co-morbidity in Dhaka, Bangladesh: A Cross-Sectional Study. Journal of Emerging Global Health. 2025 Jul 31;12(1):20–31.
12. Parvin S, Akter S, Hossain MI, Ali MS, Soni MSM. Residential variations in hypertension prevalence and trends among adults in Bangladesh. Res Health Serv Reg. 2024 Mar 27;3(1):3.
13. Ahmed S, Tariqujjaman M, Rahman MA, Hasan MZ, Hasan MM. Inequalities in the prevalence of undiagnosed hypertension among Bangladeshi adults: evidence from a nationwide survey. Int J Equity Health. 2019 Feb 15;18(1):33.
14. TAREK D, LABIBA D, AHMED D, ALAM D, AKTER D, ANNE D, et al. Prevalence and risk factors of hypertension in Bangladeshi adults. SAS JOURNAL. 2024;10(10):1149–53.
15. Iqbal A, Ahsan KZ, Jamil K, Haider MM, Khan SH, Chakraborty N, et al. Demographic, socioeconomic, and biological correlates of hypertension in an adult population: evidence from the Bangladesh demographic and health survey 2017-18. BMC Public Health. 2021 Jun 26;21(1):1229.
16. Chowdhury MAB, Islam M, Rahman J, Uddin MT, Haque MR, Uddin MJ. Changes in prevalence and risk factors of hypertension among adults in Bangladesh: An analysis of two waves of nationally representative surveys. PLoS One. 2021 Dec 2;16(12):e0259507.
17. Koly KN, Biswas T, Islam A. Increasing prevalence of hypertension in Bangladesh: a review. Cardiovascular Journal. 2015 Aug 28;8(1):59–64.
18. Rahman M, Zaman MM, Islam JY, Chowdhury J, Ahsan HN, Rahman R, et al. Prevalence, treatment patterns, and risk factors of hypertension and pre-hypertension among Bangladeshi adults. J Hum Hypertens. 2018 May;32(5):334–48.
19. Chowdhury MA, Uddin MJ, Haque MR, Ibrahimou B. Hypertension among adults in Bangladesh: evidence from a national cross-sectional survey. BMC Cardiovasc Disord. 2016 Jan 25;16:22.
20. Islam AK, Majumder AA. Hypertension in Bangladesh: a review. Indian Heart J. 2012 May-Jun;64(3):319–23.
21. Rahman MA, Halder HR, Yadav UN, Mistry SK. Prevalence of and factors associated with hypertension according to JNC 7 and ACC/AHA 2017 guidelines in Bangladesh. Sci Rep. 2021 Jul 29;11(1):15420.
22. Islam JY, Zaman MM, Haq SA, Ahmed S, Al-Quadir Z. Epidemiology of hypertension among Bangladeshi adults using the 2017 ACC/AHA Hypertension Clinical Practice Guidelines and Joint National Committee 7 Guidelines. J Hum Hypertens. 2018 Oct;32(10):668–80.
23. Irfan SR, Safdar AM, Alam MZ, Habib SH, Islam R, Hossain MS, et al. Incidence of Hypertension and Associated Cardiovascular and Metabolic Status in a Group of Official Population of Bangladesh. Bangladesh Heart Journal. 2016;31(2):52–7.
24. Kibria GMA, Swasey K, Choudhury A, Burrowes V, Stafford KA, Uddin SMI, et al. The new 2017 ACC/AHA guideline for classification of hypertension: changes in prevalence of hypertension among adults in Bangladesh. J Hum Hypertens. 2018 Sep;32(8-9):608–16.
25. Khanam PA, Begum T, Chowdhury A, Habib SH. Coronary artery disease with type 2 diabetes and other risk factors: A tertiary care hospital in Bangladesh. Bangladesh Critical Care Journal. 2019;7(1):20–5.
26. Mumu SJ, Stanaway FF, Merom D. Rural-to-urban migration, socio-economic status and cardiovascular diseases risk factors among Bangladeshi adults: A nationwide population based survey. Front Public Health. 2023 Apr 6;11:860927.
27. Farhana A, Shakil M, Khan BU, Laskar MS, Alam M. Hypertension status among the adult population in a rural community of Keraniganj Upazila, Dhaka, Bangladesh. Mediscope. 2018 Aug 24;5(2):21–9.
28. Rahman M, Tondel M, Ahmad SA, Chowdhury IA, Faruquee MH, Axelson O. Hypertension and arsenic exposure in Bangladesh. Hypertension. 1999 Jan;33(1):74–8.
29. Chowdhury R, Naheed A, Monower MM, Shahzad S, Raqib R, Tasmin I, et al. Conventional and regionally distinctive risk factors for first-onset myocardial infarction: the Bangladesh Risk of Acute Vascular Events (BRAVE) case-control study. Lancet Reg Health Southeast Asia. 2024 Dec 19;32:100519.
30. Fatema K, Zwar NA, Milton AH, Ali L, Rahman B. Prevalence of Risk Factors for Cardiovascular Diseases in Bangladesh: A Systematic Review and Meta-Analysis. PLoS One. 2016 Aug 5;11(8):e0160180.
31. Khan AE, Costopoulos E, Mojumder SK, Shilpi AB, Hoque MA, Butler A, et al. Drinking water salinity and blood pressure in coastal Bangladesh: follow-up of a population-based cohort in a climate-vulnerable region. BMJ Open. 2026 Jul 1;16(7):e116453.
32. Wu F, van Geen A, Graziano J, Ahmed KM, Liu M, Argos M, et al. Arsenic Exposure Reduction and Chronic Disease Mortality. JAMA. 2025 Dec 16;334(23):2104–12.
33. Bayraktar B, Battal F. The relationship between emotional intelligence levels, stress management skills and hormonal and cerebral responses in university students. BMC Psychol. 2025 Nov 6;13(1):1231.
34. Kirbas ZO, Bayraktar B, Aktas EO. Investigation of the relationship of cardiac troponin I and cortisol hormone levels with some variables in children: Relational screening model. Med Sci. 2024 Jun 1;13:310–4.
35. Kirbaş ZÖ, Bayraktar B, Aktaş EO. Salivary apelin hormone response and dysfunctional attitudes in adolescents in Türkiye: a relational screening model. BMC Psychol. 2024 Feb 9;12(1):64.